© Rosalind Scientific LLC 2018-2022
© Rosalind Scientific LLC, 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >3,500 drug hunters worldwide, unsubscribe anytime.
<< Back to October
oral, first-in-class CHIT1/AMCase chitinase inh.
for sarcoidosis/lung fibrosis, Ph. Ib complete
from opt. of literature molecule
J. Med. Chem., Oct. 20, 2020
OncoArendi Therapeutics SA, Warsaw, PL
OATD-01 (OncoArendi Therapeutics oral, first-in-class CHIT1/AMCase chitinase inhibitor clinical candidate)
Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.